Pharmaceutical Executive
May 25, 2010
Features
0
0
One year after the rash of pharma megamergers, Pharm Exec's annual listing of the industry's top-selling companies looks a little different. Find out who disappeared from the list, and what up-and-coming companies finally broke into the top 50.
May 01, 2010
Issue PDF
0
0
One Pill Makes You Better?
May 01, 2010
Columns
0
0
Timely and accessible information can help break through the firewall of regulation.
May 01, 2010
Features
0
0
The Orphan Drug Act of 1983 has been a roaring success. So why is everybody trying to mess with it?
May 01, 2010
Features
0
0
The new world of mobile applications is sparking creative platforms for reaching consumers and physicians.
May 01, 2010
Features
0
0
How will US healthcare reform affect drug pricing, revenue, and compliance?
May 01, 2010
From the Editor
0
0
Cash-rich Big Pharmas are hedging their bets to cover both segments under the rubric of "diversification." If it sticks to the wall, then buy it.
May 01, 2010
Columns
0
0
The three-way race for control of Parliament leaves the future of the British pharmaceutical industry in the balance.
May 01, 2010
Features
0
0
A panel of bankers and industry executives discuss what's ahead in deals for 2010.
May 01, 2010
Columns
0
0
Marketers must focus on getting busy women the help they need in making critical decisions about their healthcare.
May 01, 2010
Washington Report
0
0
Under the new healthcare regime, pharma will ante up fees and rebates in return for expanded sales and safeguards.